Fiona Barry
@fionareporter
Journo. Editor-in-Chief, GlobalData
[email protected]
[email protected]
Linkedin.com/in/fibarry
ID: 2374001503
http://muckrack.com/fiona-barry 05-03-2014 16:10:36
450 Tweet
250 Followers
119 Following
I discussed the pandemic's impact on #pharmaceutical supply chains in an interview with Chemistry World: chemistryworld.com/news/covid-19-…
COVID-19 Vaccine Manufacturing Challenges Spark Surge In Outsourcing Deals outsourcedpharma.com/doc/covid-vacc… Fiona Barry
Flurry of manufacturing deals for billions of Covid-19 vaccine doses – while CDC and Trump at odds over production timeline. My comment piece for Pharma Technology Focus #VaccinesWork #covidupdates
Former congressional leaders’ predictions about healthcare policy and legislation change under Biden’s administration pharmaceutical-technology.com/comment/us-hea… via Pharma Technology Focus
.Fiona Barry a "more immediate stress on the viral vector supply chain is their use in some #COVID19 #vaccines, specifically recombinant vector vaccines. AstraZeneca and Johnson & Johnson vaccines" expresspharma.in/bio-pharma-ind… ExpPharma
Latest report from Quentin Horgan
US Election: In close race, tiny Senate majority, not President, will hold power pharmaceutical-technology.com/analyst-commen… via Pharma Technology Focus #electionday2024 #KamalaHarris #DonaldTrump
What's the next big challenge for cell and gene therapies? Alliance for Regenerative Medicine (ARM) IB Communications Ltd youtube.com/watch?v=YUqsOS…
Trump’s agency nominations have the pharma world divided. Are they a prescription for progress or side effects waiting to happen? Read more: pharmaceutical-technology.com/analyst-commen… #PharmaPolitics #Healthcare #FDA via Pharma Technology Focus GlobalData Healthcare